non-nucleoside reverse transcriptase inhibitor
HIV Drugs in the Pipeline: Expected Approvals for 2018
Pharmaceutical companies are looking at antiretroviral therapy regimens that are easier on patients with HIV.
FEBRUARY 7, 2018

Load more